GnRH Antagonist: a New and an Effective Way of Treatment of Advanced Prostate Cancer.

Tomabal, Bertrand; Raghunath, S K; Srivatsa, N; Nagaraj, V H

Tomabal, Bertrand; Raghunath, S K; Srivatsa, N; Nagaraj, V H.

Afiliação

Tomabal B; Service d'Urologie, Cliniques universitaires Saint Luc, Universitécatholique de Louvain, Brussels, Belgium.
Raghunath SK; Department of Urooncology, HCG-Bangalore Institute of Oncology, Bangalore, India.
Srivatsa N; Department of Urooncology, HCG-Bangalore Institute of Oncology, Bangalore, India.
Nagaraj VH; Department of Urooncology, HCG-Bangalore Institute of Oncology, Bangalore, India.

Indian J Surg Oncol ; 8(3): 385-388, 2017 Sep.

Article em En | MEDLINE | ID: mdl-36118411

Palavras-chave

Cardiovascular morbidity in metastatic prostate cancer; Degarelix; Gonadotropin releasing hormone antagonists; Metastatic prostate cancer; Microsurges

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Indian J Surg Oncol Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Indian J Surg Oncol Ano de publicação: 2017 Tipo de documento: Article